Dr Reddy’s Q1 Talking Points: Solid US Gains, Mark Cuban Cost Plus Drug Co, China
A sharp upswing in the US business, an alliance with Mark Cuban’s venture and a buoyant outlook in markets like China augur well for Dr Reddy’s. Can the company sustain momentum for the rest of year?
